Donoghoe Nicholas
Donoghoe Nicholas, EVP, CB, SO, reported a transaction classified as exercise at AbbVie Inc. involving 32710.000000 shares for an estimated $2584744.20. Reported holdings after the transaction were 107140.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 14, 2026
- Filing date
- Aug 18, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ABBV price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001762951-26-000006 Common Stock, $0.01 par value
- Transaction date
- Aug 14, 2026 Filed Aug 18, 2026, 09:00 PM · 4d delay
- Shares
- 32,710 sh $79.02 per share
- Estimated value
- $2.58M Computed from shares × price
- Holdings after
- 107,140 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, CHIEF BUS/STRAT OFFICER
- F1
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual…
0 other transactions
0 recent txs